Silence Therapeutics SLN
$19.81 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.81 0.00%
Open$19.81
Prev close$19.81
Day range$19.80 – $19.83
Volume399.1K
Market cap$1.23B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00-100.0% YoY
Operating profit-$14.22M+45.8% YoY
Net profit-$12.43M+40.7% YoY
Diluted EPS-$0.24+46.7% YoY
Free cash flow-$12.78M-17.3% YoY
Operating cash flow-$12.78M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin95.0%
Operating margin-12,343.6%
Net margin-11,276.5%
Return on equity-35.6%
Return on assets-24.0%
Return on invested capital-35.5%
Current ratio23.94
Liabilities / assets23.6%
Cash & investments$247.66M
Total debt$0.00
Net cash (debt)$247.66M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $0.00 | $0.00 | $422,000.00 | $559,000.00 | $34,000.00 |
| Total Operating Revenue | $0.00 | $0.00 | $422,000.00 | $559,000.00 | $34,000.00 |
| Cost of Revenue | $0.00 | $0.00 | $11,000.00 | $215,000.00 | $12,000.00 |
| Gross Profit | $0.00 | $0.00 | $411,000.00 | $344,000.00 | $22,000.00 |
| Operating Expense | $14.22M | $13.87M | $16.15M | $90.10M | $12.48M |
| Selling and Admin Expenses | $4.92M | $4.72M | $7.03M | $22.34M | $3.73M |
| -General & Admin Expense | $4.92M | $4.72M | $7.03M | $22.34M | $3.73M |
| Research & Development | $9.30M | $9.15M | $9.12M | $67.75M | $8.75M |
| Operating Profit | -$14.22M | -$13.87M | -$15.74M | -$89.75M | -$12.46M |
| Other Income (Expense) | $1.80M | $1.60M | $780,000.00 | -$2.33M | -$2.79M |
| Gain on Sale of Security | $21,000.00 | $151,000.00 | -$482,000.00 | -$8.47M | -$19,000.00 |
| Special Income (Charges) | $0.00 | $0.00 | – | -$1.32M | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | $0.00 | – | $1.32M | $0.00 |
| Other Non-Operating Income (Expenses) | $1.78M | $1.45M | $1.26M | $7.46M | -$2.77M |
| Pretax Profit | -$12.43M | -$12.27M | -$14.96M | -$88.60M | -$11.77M |
| Tax | $0.00 | $1,000.00 | $0.00 | $11,000.00 | $0.00 |
| Net Profit | -$12.43M | -$12.27M | -$14.96M | -$88.61M | -$11.77M |
| Profit from Continuing Operations | -$12.43M | -$12.27M | -$14.96M | -$88.61M | -$11.77M |
| Net Income to Parent Company | -$12.43M | -$12.27M | -$14.96M | -$88.61M | -$11.77M |
| Net Income to Common Stockholders | -$12.43M | -$12.27M | -$14.96M | -$88.61M | -$11.77M |
| Basic EPS | -$0.24 | -$0.27 | -$0.33 | -$1.89 | -$0.27 |
| Diluted EPS | -$0.24 | -$0.27 | -$0.33 | -$1.89 | -$0.27 |
| Net Non-Operating Interest Income (Expense) | – | – | – | $3.48M | – |
| Non-Operating Interest Income | – | – | – | $3.48M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $281.50M | $106.41M | $115.12M | $131.44M | $131.44M |
| Total Current Assets | $269.58M | $94.28M | $102.85M | $118.66M | $118.66M |
| Cash and Cash Equivalents & Short-Term Investments | $247.66M | $72.05M | $70.08M | $85.11M | $85.11M |
| -Cash and Cash Equivalents | $247.66M | $72.05M | $5.66M | $11.28M | $11.28M |
| -Short Term Investments | $0.00 | $0.00 | $64.42M | $73.84M | $73.84M |
| Receivables | $9.97M | $9.29M | $22.22M | $24.61M | $24.61M |
| -Other Receivables | $9.97M | $9.29M | $22.22M | $22.01M | $22.01M |
| Other Current Assets | $11.94M | $12.94M | $10.56M | – | – |
| Total Non-Current Assets | $11.92M | $12.13M | $12.27M | $12.78M | $12.78M |
| Net PPE | $1.31M | $1.44M | $1.54M | $1.75M | $1.75M |
| -Gross PPE | $1.31M | $1.44M | $1.54M | $5.71M | $5.71M |
| Goodwill and Other Intangible Assets | $10.48M | $10.56M | $10.61M | $10.91M | $10.91M |
| -Goodwill | $10.25M | $10.33M | $10.36M | $10.62M | $10.62M |
| -Other Intangible Assets | $227,000.00 | $237,000.00 | $248,000.00 | $288,000.00 | $288,000.00 |
| Other Non-Current Assets | $127,000.00 | $127,000.00 | $127,000.00 | – | – |
| Total Liabilities | $66.48M | $67.94M | $65.72M | $69.14M | $69.14M |
| Total Current Liabilities | $11.26M | $12.71M | $10.46M | $13.61M | $13.61M |
| Payables | $11.17M | $12.61M | $10.37M | $4.64M | $4.64M |
| -Accounts Payable | $11.17M | $12.61M | $10.37M | $4.41M | $4.41M |
| Short-Term Debt and Capital Lease Obligation | $87,000.00 | $103,000.00 | $93,000.00 | $89,000.00 | $89,000.00 |
| -Current Capital Lease Obligation | $87,000.00 | $103,000.00 | $93,000.00 | $89,000.00 | $89,000.00 |
| Current Deferred Liabilities | $0.00 | $0.00 | $0.00 | $168,000.00 | $168,000.00 |
| Total Non-Current Liabilities | $55.22M | $55.23M | $55.26M | $55.53M | $55.53M |
| Long Term Debt and Capital Lease Obligation | $0.00 | $9,000.00 | $43,000.00 | $71,000.00 | $71,000.00 |
| -Long Term Capital Lease Obligation | $0.00 | $9,000.00 | $43,000.00 | $71,000.00 | $71,000.00 |
| Non-Current Deferred Liabilities | $55.22M | $55.22M | $55.22M | $55.45M | $55.45M |
| Total Equity | $215.02M | $38.47M | $49.40M | $62.30M | $62.30M |
| Stockholders' Equity | $215.02M | $38.47M | $49.40M | $62.30M | $62.30M |
| Capital Stock | $13.33M | $10.29M | $10.29M | $10.29M | $10.29M |
| -Common Stock | $13.33M | $10.29M | $10.29M | $10.29M | $10.29M |
| Additional Paid-In Capital | $807.06M | $621.15M | $620.01M | $617.56M | $617.56M |
| Retained Earnings | -$601.89M | -$589.63M | -$577.53M | -$562.57M | -$562.57M |
| Gains/Losses Not Affecting Retained Earnings | -$3.48M | -$3.34M | -$3.37M | -$2.98M | -$2.98M |
| -Accounts Receivable | – | – | $0.00 | $0.00 | $0.00 |
| -Taxes Receivable | – | – | – | $2.61M | $2.61M |
| Prepaid Assets | – | – | – | $8.93M | $8.93M |
| -Accumulated Depreciation | – | – | – | -$3.96M | -$3.96M |
| Non-Current Prepaid Assets | – | – | – | $127,000.00 | $127,000.00 |
| -Total Tax Payable | – | – | – | $234,000.00 | $234,000.00 |
| Current Accrued Expenses | – | – | – | $5.75M | $5.75M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$12.78M | $1.52M | -$15.60M | -$62.27M | -$17.29M |
| Net cash flow from continuing operations | -$12.78M | $1.52M | -$15.60M | -$62.27M | -$17.29M |
| Net Income from Continuing Operations | -$12.43M | -$12.27M | -$14.96M | -$88.61M | -$11.77M |
| Gain/Loss from Continuing Operations | -$79,000.00 | $178,000.00 | -$25,000.00 | $11.02M | $230,000.00 |
| Depreciation & Depletion & Amortization | $106,000.00 | $108,000.00 | $106,000.00 | $555,000.00 | $113,000.00 |
| Deferred Tax | $0.00 | – | – | $11,000.00 | $0.00 |
| Other Non-Cash Items | $0.00 | -$584,000.00 | -$519,000.00 | -$3.48M | -$880,000.00 |
| Change in Working Capital | -$1.15M | $12.78M | -$2.66M | $10.16M | -$4.89M |
| -Change in Receivables | -$681,000.00 | $12.92M | -$209,000.00 | $5.07M | $220,000.00 |
| -Change in Payables and Accrued Expense | -$1.44M | $2.20M | -$2.95M | -$4.08M | -$3.58M |
| -Change in Other Current Assets | $991,000.00 | -$2.33M | $931,000.00 | $9.67M | -$1.48M |
| -Change in Other Current Liabilities | -$25,000.00 | -$24,000.00 | -$24,000.00 | -$168,000.00 | -$22,000.00 |
| -Change In Other Working Capital | $0.00 | $0.00 | -$404,000.00 | -$334,000.00 | -$32,000.00 |
| Net cash flow from investing | $0.00 | $64.94M | $10.00M | -$47.99M | -$53.34M |
| Net Cash Flow from Continuing Investing Activities | $0.00 | $64.94M | $10.00M | -$47.99M | -$53.34M |
| Net PPE Purchase and Sale | $0.00 | $0.00 | $0.00 | -$55,000.00 | $0.00 |
| Net Investment Purchase and Sale | $0.00 | $64.94M | $10.00M | -$47.94M | -$53.34M |
| Financing Cash Flow | $188.33M | $2,000.00 | $0.00 | $15,000.00 | $0.00 |
| Net Cash Flow from Continuing Financing Activities | $188.33M | $2,000.00 | $0.00 | $15,000.00 | $0.00 |
| Net Common Stock Issuance | $188.33M | $2,000.00 | $0.00 | $15,000.00 | $0.00 |
| Ending Cash Balance | $247.66M | $72.05M | $5.66M | $11.28M | $11.28M |
| Net Change in Cash | $175.56M | $66.46M | -$5.60M | -$110.25M | -$70.63M |
| Beginning Cash Balance | $72.05M | $5.66M | $11.28M | $121.33M | $82.03M |
| Effect of Exchange Rate Changes | $48,000.00 | -$63,000.00 | -$17,000.00 | $195,000.00 | -$129,000.00 |
| Free Cash Flow | -$12.78M | $1.52M | -$15.60M | -$62.33M | -$17.29M |
No comments yet — be the first to weigh in on SLN.
Sign in to join the discussion.